ANIP
ANIP
US00182C1036
ANI Pharmaceuticals, Inc.
Loading chart...

Company Profile

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Latest News

Related stocks

PAHC
PAHC • United States
Phibro Animal Health Corporatio
38.3 USD
1.56B USD 1Y +0.8%
BCRX
BCRX • United States
BioCryst Pharmaceuticals, Inc.
8.55 USD
2.18B USD 1Y +13.9%
SUPN
SUPN • United States
Supernus Pharmaceuticals, Inc.
42.67 USD
2.48B USD 1Y -12.2%
PBH
PBH • United States
Prestige Consumer Healthcare In
48.23 USD
2.28B USD 1Y -24.4%
PCRX
PCRX • United States
Pacira BioSciences, Inc.
36.31 USD
1.45B USD 1Y +55.4%
LQDA
LQDA • United States
Liquidia Corporation
27.38 USD
2.45B USD 1Y +16.4%
XERS
XERS • United States
Xeris Biopharma Holdings, Inc.
10.48 USD
1.91B USD 1Y +24.3%
ETON
ETON • United States
Eton Pharmaceuticals, Inc.
55.21 USD
1.58B USD 1Y +161.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
45.5% p.a.
Max Drawdown (5Y)
-59.4%
Sharpe Ratio (5Y)
0.26
Beta Factor
0.49
Size Class
Small Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (45.5% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -73.0% in the extended horizon.
ende